Epidiolex is the licensed CBD (cannabidiol) isolate (single chemical) produced by GW pharmceutical. It is licensed for two forms for drug resistant epilespy in combination with clobazam (Lennox Gastauts Syndrome and Dravet's Syndrome).
Medical Cannabis: Expert Opinion and Patient-Centred Treatment
A comprehensive, prospective registry designed to collate outcomes on medical cannabis prescribing.
Helping reduce the financial barriers of access to medical cannabis
Subscribe to Sapphire via Email
Sign up to hear news from Sapphire including our clinic openings and industry updates relating to access to medical cannabis